Previous Article
Journal of Bacteriology, June 2003, p. 3480-3483, Vol. 185, No. 11
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.11.3480-3483.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Synthesis and Localization of the Salmonella SPI-1 Type III Secretion Needle Complex Proteins PrgI and PrgJ
Anand Sukhan,
Tomoko Kubori, and Jorge E. Galán*
Section of Microbial Pathogenesis, Yale School of Medicine, New Haven, Connecticut 06536
Received 3 December 2002/
Accepted 20 March 2003

ABSTRACT
An essential component of type III secretion systems (TTSS)
is a supramolecular structure termed the needle complex. In
Salmonella enterica, at least four proteins make up this structure:
InvG, PrgH, PrgK, and PrgI. Another protein, PrgJ, is thought
to play a role in the assembly of this structure, but its function
is poorly understood. We have analyzed the expression and localization
of PrgJ and the needle protein PrgI in different
S. enterica serovar Typhimurium mutant strains. We found that the levels
of PrgI and PrgJ were significantly reduced in a TTSS-deficient
invA mutant strain and that the decreased levels were due to
protein instability. In addition, we found that PrgJ, although
associated with the needle complex in wild-type
S. enterica serovar Typhimurium, was absent from needle complexes obtained
from an
invJ mutant strain, which exhibits very long needle
substructures. We suggest that PrgJ is involved in capping the
needle substructure of the needle complex.

TEXT
The ability of
Salmonella enterica to interact with intestinal
epithelial cells is dependent on the presence of a type III
secretion system (TTSS) encoded in
Salmonella pathogenicity
island 1 (SPI-1) (
4). Essential for the function of this system
is a membrane-spanning protein structure known as the needle
complex (
7). This structure is composed of at least four proteins:
InvG, a member of the secretin family of proteins, which is
homologous to components of both type II secretion and pilus
assembly systems, and the products of the
prg operon, PrgH,
PrgI, and PrgK. InvG, PrgH, and PrgK have been shown to form
the membrane-localized base substructure of the needle complex
(
7), while PrgI forms the needle portion of the complex (
8).
Another, putative component of the needle complex is PrgJ, which
is also encoded within the
prg operon (
1). The location of PrgJ
in the needle complex, its potential relationship with other
components of this structure such as PrgI, and its putative
role in the assembly of the needle complex are unknown. In order
to gain a better understanding of these issues, we examined
the expression and localization of PrgI and PrgJ in the wild
type as well as selected
S. enterica serovar Typhimurium mutant
strains.
We have previously shown that the needle portion of the needle complex is absent in a number of mutant strains, including an invA and a prgJ mutant (11). Conversely, an invJ mutant was shown to produce extraordinarily long needles (8). We were interested in determining if the expression of PrgI and PrgJ was affected in these mutant strains. We examined the levels of PrgI and PrgJ in the invA, invJ, and prgJ mutant strains and compared them to those in the wild type. Bacteria were grown under SPI-1-inducing conditions (3), 1-ml samples were removed, and proteins were precipitated by the addition of trichloroacetic acid (TCA). Immunoblot analysis of the protein pellets revealed that PrgI was significantly reduced in the invA mutant and could not be detected in the prgJ mutant (Fig. 1). In contrast, the amount of PrgI produced by the invJ mutant strain was slightly increased in comparison to that in the wild type (Fig. 1), a finding that is consistent with the fact that this strain produces abnormally long needles (8). PrgJ could not be detected in the invA mutant (Fig. 1). In contrast, the amount of PrgJ detected in the invJ mutant was somewhat higher than that in the wild type (Fig. 1). The fact that the level of PrgJ is elevated in an invJ mutant (which has extra-long needles) and absent in an invA mutant (which lacks needles) suggests that this protein may be involved in the assembly of the needle portion of the S. enterica serovar Typhimurium SPI-1 needle complex.
In order to determine if the differences seen in PrgI and PrgJ
protein levels in the different SPI-1 mutant strains were due
to differential transcriptional regulation, the transcription
of the
prgI and
prgJ genes was monitored with the use of
xylE reporter gene fusions. A
xylE reporter gene cassette lacking
a transcription terminator was inserted into either
prgI or
prgJ, and the fusions were recombined into the chromosome of
the wild type as well as the
invA,
invJ, and
prgJ mutant strains
as previously described (
5). Introduction of this cassette does
not lead to polar effects on downstream genes (
5). The expression
of the different reporter gene fusions was monitored in the
resulting strains grown under SPI-1-inducing conditions by assaying
catechol-2,3-dioxygenase activity in bacterial lysates (
5).
Although differences in the levels of catechol-2,3-dioxygenase
activity between the wild type and some of the mutant strains
carrying the
prgI or
prgJ reporter fusions were detected (Table
1), these differences were opposite to what would be expected
based on the protein expression experiments (Fig.
1). For example,
the transcription of both the
prgI-xylE and the
prgJ-xylE fusions
was higher in the
invA mutant background and lower in the
invJ mutant strain than in the wild type, which does not strictly
correlate with the levels of these proteins as determined by
Western blotting (Fig.
1). Equivalent results were obtained
when merodiploid reporter strains were utilized in these experiments,
ruling out potential feedback regulatory mechanisms (data not
shown). In addition, equivalent results were also obtained with
plasmid-borne reporter fusions or in the presence of a plasmid-borne
wild-type copy of the respective genes (data not shown). While
these experiments indicate that there may be slight differences
in the abilities of these strains to transcribe
prgI and
prgJ,
these differences cannot explain the changes in protein expression
observed among these different strains.
Since the changes in the levels of PrgI and PrgJ observed in
the various mutant strains could not be explained by the differences
in transcription, we wanted to determine if they were due to
differences in mRNA translation. We therefore constructed in-frame
fusions of
prgI and
prgJ to
lacZ to monitor translation. Single-copy
plasmids containing either the
prgI-lacZ or the
prgJ-lacZ gene
fusion were electroporated into the wild type and the
invA,
invJ, and
prgJ mutant strains, and their translation was monitored
by measuring the levels of ß-galactosidase activity.
The expression of the different fusion proteins was under the
control of their native promoters. As seen in Table
2, the translation
of both the
prgI-lacZ and the
prgJ-lacZ gene fusions, as measured
by ß-galactosidase activity, did not significantly
vary regardless of which strain background they were placed
in. Interestingly, the levels of ß-galactosidase activity
in the strains carrying the
prgI-lacZ fusion were approximately
10 times higher than those found in the strains carrying the
prgJ-lacZ fusion. Since both
prgI and
prgJ were under the control
of the same promoter, this finding would indicate that the translation
of
prgI is more efficient than the translation of
prgJ, which
is consistent with the fact that PrgI is the main (or only)
subunit of the needle substructure (
8). Alternatively, it is
also possible that this difference reflects different stabilities
of the PrgI and PrgJ reporter fusions.
Since the reduction of PrgI and PrgJ levels in the
invA mutant
did not appear to be due to differences in transcription or
translation, we examined the possibility that the differences
in protein levels could be due to differences in protein stability.
Given the small size of these proteins and their low cysteine-methionine
content, a pulse-chase experiment using
35S-labeled amino acids
was not feasible. We therefore used an alternative strategy
to examine the stability of these proteins. Both the wild type
and the
invA mutant were transformed with a plasmid containing
the
prgJ gene under control of an arabinose-inducible promoter.
The bacteria were grown under SPI-1-inducing conditions in media
containing arabinose. At an optical density at 600 nm (OD
600)
of 0.8, chloramphenicol was added to halt de novo protein synthesis,
and the levels of PrgJ at different times after addition of
chloramphenicol were determined by immunoblot analysis. As seen
in Fig.
2, the amount of PrgJ in the wild-type strain remained
consistent over the course of the experiment, whereas the amount
of PrgJ in the
invA mutant decreased significantly. These findings
indicate that the reduced level of PrgJ in the
invA mutant is
due to protein instability. We were unable to overexpress PrgI;
therefore, we could not perform similar experiments to determine
the stability of PrgI in the
invA mutant. However, it is likely
that the lower level of PrgI seen in this mutant is also due
to protein instability.
To further investigate the relationship between PrgI and PrgJ,
we separated bacterial cultures of the wild type and the
invA and
invJ mutants into supernatants, needle complexes, and cytosolic
components in order to determine the location of these two proteins
in these strains. Cultures were grown under SPI-1 TTSS-inducing
conditions and separated into the three different components.
Western blot analysis revealed that in the wild type, the majority
of PrgI was located in the culture supernatant and the needle
complex fraction (Fig.
3). Only a very small amount of PrgI
could be detected in the cytosol when the blot was overexposed
(data not shown). When we examined the
invJ mutant we found
that the localization of PrgI was similar to that seen in the
wild type: PrgI was detected predominantly in the culture supernatant
and the needle complex fractions. We also found that in the
wild type, the majority of PrgJ was located in the culture supernatant,
with a smaller amount located in the needle complex fraction
(note that for the PrgJ localization analysis, 5 ml of both
the membrane and the cytosolic fractions was loaded, in comparison
to 2 ml of culture supernatant fraction; see the legend to Fig.
3). No PrgJ could be detected in the cytosol. As expected, we
did not detect PrgI and PrgJ in any fraction of the
invA mutant
strain (Fig.
3). In contrast to the wild type, we found that
in the
invJ mutant strain PrgJ could be detected only in the
culture supernatant. No PrgJ could be detected in the needle
complex fraction isolated from this strain. This finding is
surprising given that this mutant not only is capable of expressing
and secreting PrgJ but does so in amounts greater than those
in the wild-type strain. The absence of PrgJ in the needle complex
of the
invJ mutant, which assembles abnormally long needle substructures,
suggests a role for PrgJ in the termination of needle assembly
in conjunction with InvJ. These data also suggest that PrgJ
may function as a capper of the needle substructure.
It has recently been proposed that MxiI, the
Shigella homolog
of PrgJ, may be located at the tip of the closely related needle
complex of the
Shigella TTSS (
2), although no direct evidence
for this hypothesis was provided. In order to determine if PrgJ
is located at the tip of the
Salmonella needle complex, we performed
an experiment in which the needle portion of the complex was
sheared from the surface of whole cells and examined for its
protein content. Wild-type bacteria were grown under inducing
conditions, harvested, washed, and passed through a 25-gauge
needle 20 times in order to shear off the needle substructure.
The amount of PrgI and PrgJ found in the sheared fraction was
compared to that found in the cell envelope. A sample of membrane-associated
protein from an unsheared sample was included as a control.
As seen in Fig.
4, a significant proportion of PrgI is clearly
detectable in the sheared fraction, a finding that is in keeping
with its surface localization (
8). In contrast, no PrgJ could
be detected in the sheared fraction. Given the small amount
of PrgJ found in the needle complex compared to PrgI, these
findings do not rule out the possibility that PrgJ may be part
of the needle substructure. However, it seems unlikely that
PrgJ is located at the tip of the needle, since it is this region
that would be the most likely to break off during the shearing
procedure. These results are also in keeping with our inability
to detect PrgJ at the tip of the needle substructure by immunoelectron
microscopy (data not shown). It is possible that PrgJ may be
located at the base of the needle substructure, where it may
exert its capping and needle assembly termination functions
in conjunction with InvJ. This hypothesis would imply that the
needle assembly may occur by subunit addition at the base of
the substructure rather than at the tip. Alternatively, it is
also possible that PrgJ may serve as an "adaptor" molecule that
mediates the anchoring of the PrgI needle filament to the base
structure. More experiments will be required to substantiate
this hypothesis.
In summary, we have shown that (i) in comparison to the levels
in the wild-type strain, the levels of PrgI and PrgJ are reduced
in an
invA mutant and are increased in an
invJ mutant; (ii)
the lower levels of PrgI and PrgJ in the
invA mutant are likely
due to protein instability; (iii) PrgJ is not associated with
the needle complex of the
invJ mutant, suggesting a role for
this protein in the capping of the needle complex; and (iv)
PrgJ does not appear to be located at the tip of the needle.
Further studies will be required to precisely ascertain the
function of PrgJ in the control of needle assembly.

ACKNOWLEDGMENTS
We thank members of the Galán laboratory for critical
review of the manuscript.
This work was supported by Public Health Service grant AI30492 from the National Institutes of Health.

FOOTNOTES
* Corresponding author. Mailing address: Section of Microbial Pathogenesis, Yale School of Medicine, 296 Congress Ave., Rm. 354E, New Haven, CT 06536-1418. Phone: (203) 737-2404. Fax: (203) 737-2630. E-mail:
jorge.galan{at}yale.edu.

Present address: Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078. 

REFERENCES
1 - Behlau, I., and S. J. Miller. 1993. A Pho-P-repressed gene promotes Salmonella typhimurium invasion of epithelial cells. J. Bacteriol. 175:4475-4484.[Abstract/Free Full Text]
2 - Blocker, A., N. Jouihri, E. Larquet, P. Gounon, F. Ebel, C. Parsot, P. Sansonetti, and A. Allaoui. 2001. Structure and composition of the Shigella flexneri "needle complex," a part of its type III secreton. Mol. Microbiol. 39:652-663.[CrossRef][Medline]
3 - Eichelberg, K., and J. E. Galán. 1999. Differential regulation of Salmonella typhimurium type III secreted proteins by pathogenicity island 1 (SPI-1)-encoded transcriptional activators InvF and HilA. Infect. Immun. 67:4099-4105.[Abstract/Free Full Text]
4 - Galán, J. E. 2001. Salmonella interaction with host cells: type III secretion at work. Annu. Rev. Cell Dev. Biol. 17:53-86.[CrossRef][Medline]
5 - Kaniga, K., J. C. Bossio, and J. E. Galán. 1994. The Salmonella typhimurium invasion genes invF and invG encode homologues to the PulD and AraC family of proteins. Mol. Microbiol. 13:555-568.[CrossRef][Medline]
6 - Klein, J. R., T. F. Fahlen, and B. D. Jones. 2000. Transcriptional organization and function of invasion genes within Salmonella enterica serovar Typhimurium pathogenicity island 1, including the prgH, prgI, prgJ, prgK, orgA, orgB, and orgC genes. Infect. Immun. 68:3368-3376.[Abstract/Free Full Text]
7 - Kubori, T., Y. Matsushima, D. Nakamura, J. Uralil, M. Lara-Tejero, A. Sukhan, J. E. Galán, and S.-I. Aizawa. 1998. Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science 280:602-605.[Abstract/Free Full Text]
8 - Kubori, T., A. Sukhan, S. -I. Aizawa, and J. E. Galán. 2000. Molecular characterization and assembly of the needle complex of the Salmonella typhimurium type III protein secretion system. Proc. Natl. Acad. Sci. USA 97:10225-10230.[Abstract/Free Full Text]
9 - Maniatis, T., E. F. Fritsch, and J. Sambrook. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
10 - Simons, R. W., F. Houman, and N. Kleckner. 1987. Improved single and multicopy lac-based cloning vectors for protein and operon fusions. Gene 53:85-96.[CrossRef][Medline]
11 - Sukhan, A., T. Kubori, J. Wilson, and J. E. Galán. 2001. Genetic analysis of assembly of the Salmonella enterica serovar Typhimurium type III secretion-associated needle complex. J. Bacteriol. 183:1159-1167.[Abstract/Free Full Text]
Journal of Bacteriology, June 2003, p. 3480-3483, Vol. 185, No. 11
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.11.3480-3483.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Wood, S. E., Jin, J., Lloyd, S. A.
(2008). YscP and YscU Switch the Substrate Specificity of the Yersinia Type III Secretion System by Regulating Export of the Inner Rod Protein YscI. J. Bacteriol.
190: 4252-4262
[Abstract]
[Full Text]
-
Betts, H. J., Twiggs, L. E., Sal, M. S., Wyrick, P. B., Fields, K. A.
(2008). Bioinformatic and Biochemical Evidence for the Identification of the Type III Secretion System Needle Protein of Chlamydia trachomatis. J. Bacteriol.
190: 1680-1690
[Abstract]
[Full Text]
-
Fardini, Y., Chettab, K., Grepinet, O., Rochereau, S., Trotereau, J., Harvey, P., Amy, M., Bottreau, E., Bumstead, N., Barrow, P. A., Virlogeux-Payant, I.
(2007). The YfgL Lipoprotein Is Essential for Type III Secretion System Expression and Virulence of Salmonella enterica Serovar Enteritidis. Infect. Immun.
75: 358-370
[Abstract]
[Full Text]
-
Clavijo, R. I., Loui, C., Andersen, G. L., Riley, L. W., Lu, S.
(2006). Identification of Genes Associated with Survival of Salmonella enterica Serovar Enteritidis in Chicken Egg Albumen. Appl. Environ. Microbiol.
72: 1055-1064
[Abstract]
[Full Text]
-
Garmendia, J., Frankel, G., Crepin, V. F.
(2005). Enteropathogenic and Enterohemorrhagic Escherichia coli Infections: Translocation, Translocation, Translocation. Infect. Immun.
73: 2573-2585
[Full Text]
-
Marlovits, T. C., Kubori, T., Sukhan, A., Thomas, D. R., Galan, J. E., Unger, V. M.
(2004). Structural Insights into the Assembly of the Type III Secretion Needle Complex. Science
306: 1040-1042
[Abstract]
[Full Text]